Ligand Pharmaceuticals is a Jupiter, Florida-based royalty aggregator and capital provider for biopharmaceutical companies financing late-stage development programs. It manages a diversified portfolio of biopharmaceutical royalties across commercial, clinical and preclinical-stage programs and is relevant to later-stage venture rounds in biotechnology, pharmaceuticals and life sciences across the United States.